Characterization of fibroblast growth factor 1 in obese children and adolescents

Anru Wang; Xueqin Yan; Cai Zhang; Caiqi Du; Wenjun Long; Di Zhan; Xiaoping Luo

doi:10.1530/EC-18-0141

Characterization of fibroblast growth factor 1 in obese children and adolescents

Endocr Connect. 2018 Aug 1;7(8):932-940. doi: 10.1530/EC-18-0141.

Authors

Anru Wang^{1

2}, Xueqin Yan³, Cai Zhang¹, Caiqi Du¹, Wenjun Long¹, Di Zhan¹, Xiaoping Luo¹

Affiliations

¹ Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
² Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
³ Department of Pediatrics, Boai Hospital of Zhongshan, Zhongshan, China

Abstract

Background: Fibroblast growth factor 1 (FGF1) can regulate glucose and lipid metabolism in obese mice. Serum FGF1 has increased in type 2 diabetes mellitus adults and correlated with BMI. This study aimed to indicate conventional weight loss effects on FGF1 in obese children and adolescents.

Materials and methods: Clinical and metabolic parameters of 88 lean and obese individuals (ages 5–15 years) and 39 obese individuals followed with 6 months of lifestyle intervention were collected. Serum FGF1 levels were detected through enzyme-linked immunosorbent assays.

Results: FGF1 levels were increased in obese individuals. Serum FGF1 levels were significantly correlated with BMI and waist circumferences (r = 0.377, P = 0.012; r = 0.301, P = 0.047, respectively). Multivariate stepwise linear regression analyses showed that FGF1 levels were significantly correlated with HbA1c and HOMA-IR (β = 0.371, P = 0.008; β = 0.323, P = 0.021, respectively). Weight loss (2.3 ± 0.1 kg) was accompanied by a significant reduction of circulating FGF1 levels (7.2 ± 0.4 pg/mL). Changes in FGF1 were significantly correlated with changes in fasting glucose, HOMA-IR and low-density lipoprotein cholesterol (β = 0.277, P = 0.020; β = 0.474, P < 0.001; β = 0.320, P = 0.008, respectively).

Conclusion: FGF1 levels were increased in obese individuals. Serum FGF1 levels were significantly correlated with BMI and waist circumferences (r = 0.377, P = 0.012; r = 0.301, P = 0.047, respectively). Multivariate stepwise linear regression analyses showed that FGF1 levels were significantly correlated with HbA1c and HOMA-IR (β = 0.371, P = 0.008; β = 0.323, P = 0.021, respectively). Weight loss (2.3 ± 0.1 kg) was accompanied by a significant reduction of circulating FGF1 levels (7.2 ± 0.4 pg/mL). Changes in FGF1 were significantly correlated with changes in fasting glucose, HOMA-IR and low-density lipoprotein cholesterol (β = 0.277, P = 0.020; β = 0.474, P < 0.001; β = 0.320, P = 0.008, respectively).

Keywords: fibroblast growth factor 1; weight loss; children and adolescents; obesity.